ArticleGenes & diseases2024

Corrigendum to 'Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics' [Genes & Diseases 10 (2023) 1367-1401].

Uttpal Anand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.